Literature DB >> 1677257

Laterality, maldescent, trauma and other clinical factors in the epidemiology of testis cancer in Victoria, Australia.

J M Stone1, D G Cruickshank, T F Sandeman, J P Matthews.   

Abstract

Clinical factors were studied in a population based survey of 1,116 cases of testicular neoplasms in Victoria, Australia, between 1950 and 1978. The ratio of right to left sided tumours was 54:46, but the left side predominated among sarcomas (P = 0.006), and in older men. The relative risk (RR) for men with unilateral maldescent was 15 (CI 10-23) and for men with bilateral maldescent 33 (CI 20-55) (odds ratio 1.4, CI 0.5-4, P = 0.7). Calculations per testis in men with unilateral maldescent showed an elevated risk for both the maldescended testis (RR 28, CI 19-41, P less than 0.0001) and the normally descended testis (RR 3, CI 1.2-6, P = 0.04). The RR for men with abdominal maldescent was 55 (CI 36-83) compared to 7 (CI 4-11) for those with inguinal maldescent (odds ratio 8, CI 3-20, P less than 0.0001). Seminomas were more common than nonseminomas (NSGCT) in men with a history of maldescent (odds ratio 1.7, CI 1.1-3, P = 0.02) and also among corrected cryptorchids compared to uncorrected (P = 0.005). Seminomas were diagnosed at an earlier median age in men with corrected cryptorchid testes compared to uncorrected (P = 0.03) and in men with corrected cryptorchid testes compared to normally descended (P = 0.001). Maldescent was also associated with hernia (P = 0.04). Twenty-eight per cent of patients recorded a history of trauma with a higher proportion among NSGCT than among seminomas (P = 0.03). Prior malignancies were reported in nine patients, compared to 3.6 expected; prostate cancer (2) and malignant melanoma (2) were the greatest contributors to the excess.

Entities:  

Mesh:

Year:  1991        PMID: 1677257      PMCID: PMC1977325          DOI: 10.1038/bjc.1991.256

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  Testicular cancer in young men: the search for causes of the epidemic increase in the United States.

Authors:  L M Brown; L M Pottern; R N Hoover
Journal:  J Epidemiol Community Health       Date:  1987-12       Impact factor: 3.710

2.  Cryptorchidism, hernia, and cancer of the testis.

Authors:  A S Morrison
Journal:  J Natl Cancer Inst       Date:  1976-04       Impact factor: 13.506

Review 3.  The epidemiology of testicular cancer.

Authors:  Y D Senturia
Journal:  Br J Urol       Date:  1987-10

4.  Effect of age at orchidopexy on risk of testicular cancer.

Authors:  M C Pike; C Chilvers; M J Peckham
Journal:  Lancet       Date:  1986-05-31       Impact factor: 79.321

5.  Epidemiologic comparison of cancer of the testis and Hodgkin's disease among young males.

Authors:  G R Newell; P K Mills; D E Johnson
Journal:  Cancer       Date:  1984-09-15       Impact factor: 6.860

6.  Testicular cancer in cryptorchids.

Authors:  M A Batata; F C Chu; B S Hilaris; W F Whitmore; R B Golbey
Journal:  Cancer       Date:  1982-03-01       Impact factor: 6.860

7.  Second cancer following cancer of the male genital system in Connecticut, 1935-82.

Authors:  R A Kleinerman; J V Liebermann; F P Li
Journal:  Natl Cancer Inst Monogr       Date:  1985-12

8.  Summary: multiple primary cancers in Connecticut, 1935-82.

Authors:  R E Curtis; J D Boice; R A Kleinerman; J T Flannery; J F Fraumeni
Journal:  Natl Cancer Inst Monogr       Date:  1985-12

9.  Testicular cancer risk in boys with maldescended testis: a cohort study.

Authors:  A Giwercman; J Grindsted; B Hansen; O M Jensen; N E Skakkebaek
Journal:  J Urol       Date:  1987-11       Impact factor: 7.450

10.  Bilateral synchronous germ cell tumors.

Authors:  B J Miles; V J Kiesling; W D Belville
Journal:  J Urol       Date:  1985-04       Impact factor: 7.450

View more
  15 in total

1.  Management of the impalpable testis: the role of laparoscopy.

Authors:  C T Baillie; G Fearns; L Kitteringham; R R Turnock
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

Review 2.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

3.  Regional variations in testicular cancer rates in Ireland.

Authors:  M Alsinnawi; M R Quinlan; S Deady; E A Kiely
Journal:  Ir J Med Sci       Date:  2010-11-19       Impact factor: 1.568

4.  Vasectomy and testicular cancer.

Authors:  R R West
Journal:  BMJ       Date:  1992-03-21

5.  Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.

Authors:  Delphine Carouge; Valerie Blanc; Sue E Knoblaugh; Robert J Hunter; Nicholas O Davidson; Joseph H Nadeau
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-31       Impact factor: 11.205

6.  Testicular neoplasms. Evaluation of the experience during 25 years in a military hospital.

Authors:  Ramón Diz-Rodríguez; Miguel Vírseda-Chamorro; Pedro Paños-Lozano; Antonio Colmenarejo Rubio; Ignacio Arance-Gil; Ana Moreno Posadas
Journal:  Clin Transl Oncol       Date:  2006-09       Impact factor: 3.405

Review 7.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

8.  Left-right asymmetry in neck lymph nodes distribution in patients with bilateral laryngeal cancer.

Authors:  Ozgur Yoruk; Ramazan Yuksel; Yasemin Yuksel; Senol Dane
Journal:  Surg Radiol Anat       Date:  2013-07-30       Impact factor: 1.246

9.  Endogenous DNA damage and testicular germ cell tumors.

Authors:  M B Cook; A J Sigurdson; I M Jones; C B Thomas; B I Graubard; L Korde; M H Greene; K A McGlynn
Journal:  Int J Androl       Date:  2008-07-24

10.  Asymmetric Cancer Hallmarks in Breast Tumors on Different Sides of the Body.

Authors:  Emanuel M Campoy; Sergio R Laurito; María T Branham; Guillermo Urrutia; Angela Mathison; Francisco Gago; Javier Orozco; Raul Urrutia; Luis S Mayorga; María Roqué
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.